NJ ACTS Highlights

Using Artificial Intelligence and Innovative Design to Save Patient’s Lives During the COVID19 Pandemic
June 14, 2022

Learn how two groups of Princeton researchers, including NJ ACTS TL1 fellow Tom Zajdel and his mentor Daniel Cohen, developed The People’s Ventilator: a fully open, low-cost, pressure-controlled ventilator research platform compatible with adult and pediatric uses. Read the story and the published paper

NJ ACTS Pilot Grants Program - Applications due June 17
April 8, 2022

The NJ ACTS 2022 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 5 categories for potential pilot projects with awards up to $100,000 available.

Translational and Clinical…
NJ ACTS Pilot Grants Program - Now Accepting Letters of Intent due May 6
April 8, 2022

The NJ ACTS 2022 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 5 categories for potential pilot projects with awards up to $100,000 available. Please see the Pilot Program Grants page for more details and to review the Request for Applications. Required Letters of Intent are due May 6 and applications are due June 17. 

Spinout from NJ ACTS Awardee Zemer Gitai's Lab Announces Seed Funding
March 20, 2022

Funding will advance discovery of novel anti-infectives addressing antimicrobial resistance.

ArrePath, a drug discovery spinout founded by Zemer Gitai, the Edwin Grant Conklin Professor of Biology…

NIH-Funded Fellowship Program Accepting Applications - LOI Due March 31, Applications April 22
March 10, 2022

NJ ACTS is pleased to announce the NIH-funded clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. Required Letters of Intent are due March 31, 2022 by 5 pm. Applications are due April 22, 2022 by 5 pm.

Please visit the Become a TL1 Fellow section of the 

NJ ACTS Princeton Pilot Awardee Selected for Science Center Innovation Funding
Jan. 26, 2022

A Princeton-led technology to improve the storage and transport of vaccines and life-saving drugs at room temperature has been selected as one of three university innovations to receive funding for further development from the Philadelphia-based University City Science Center. The technology was developed by Princeton Research Scholar 

Princeton Neuroscience Institute Postdoc Christos Suriano awarded NIH-Funded NJ ACTS Fellowship
Nov. 22, 2021

Christos Suriano, a postdoctoral researcher in the Princeton Neuroscience Institute (PNI), was awarded a prestigious TL1 fellowship from the New Jersey Alliance for Clinical and Translational Science (NJ ACTS).

Suriano, who works in the lab of Lisa Boulanger, associate professor of…

NJ ACTS Translational Science Fellowships Awarded to Princeton's Esmat Hegazi and Rebecca Kim-Yip
Oct. 21, 2021

Two members of Princeton's Molecular Biology Department, graduate student Esmat Hegazi (Muir lab) and postdoctoral researcher Rebecca Kim-Yip (Toettcher and Posfai labs), recently joined the NIH-funded NJ ACTS TL1…

Partnership & Innovation Program Now Accepting Applications - Due August 2, 2021
July 9, 2021

The 2021 Partnership & Innovation Accelerator Pilot Program provides up to $10,000 to facilitate collaboration with local organizations on health research that benefits our communities. Learn more and read the Request for Application here. Letters of Intent are required and due July 23,…

NIH CTSA Fellowship Program - Letters of Intent Due April 30, 2021
April 9, 2021

NJ ACTS is pleased to announce a clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. Required Letters of Intent are due April 30, 2021 by 5 pm. Applications are due May 27, 2021 by 5 pm.

Please visit the 

NJ ACTS Pilot Grants Program Applications - LOI Due 3/19/21, Applications Due 4/16/21
March 1, 2021

The NJ ACTS 2021 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 4 categories for potential pilot projects with awards up to $110,000 available.

Translational and Clinical…
Postdoc Susan Legget Awarded NJ ACTS Fellowship to Study Aggressive Cancer
Jan. 28, 2021

Susan Leggett, a postdoctoral research associate in chemical and biological engineering, has received a two-year fellowship from the New Jersey Alliance for Clinical and Translational Science. The fellowship will allow her to develop her skills as a translational scientist, advance her cancer research, and provide mentoring by physician…

Covid-19 Reduced U.S. life Expectancy, Especially Among Black and Latino Populations
Jan. 14, 2021

Due to the pandemic deaths last year, life expectancy at birth for Americans will shorten by 1.13 years to 77.48 years, according to a study co-authored by Noreen Goldman of Princeton SPIA, and published in the Proceedings of the National Academy of Sciences. That is the largest single-year decline in life expectancy in…

Princeton NJ ACTS Fellow Tom Zajdel: From Skin Wounds to Ventilators
Nov. 10, 2020

Talk to Princeton Postdoctoral Research Fellow Tom J. Zajdel long enough, and the egalitarian streak comes out.

Zajdel, 30, who has been at the University’s School of Mechanical & Aerospace Engineering for nearly two years, spent plenty of time during our conversation discussing electrical stimulation and environmental biosensing…

Career Development Award for Early Stage Faculty - Applications Due November 2
Aug. 13, 2020

NJ ACTS is soliciting applications from junior faculty for its Institutional Career Development (KL2) program. The second class of KL2 Scholars will be appointed starting July 1, 2021. To learn more about the program, award provisions, eligibility criteria and requirements, and application instructions, 

NIH CTSA Fellowship Program - Applications were due July 3, 2020
June 5, 2020

NJ ACTS is pleased to announce a clinical and translational science fellowship opportunity for graduate students and postdoctoral trainees. 

Please visit the Training Awards page to review the program overview and Request for Applications, and to access the Application due July 3.

 

Princeton AI Tool Gives Doctors a New Look at the Lungs in Treating COVID-19
June 3, 2020

Spurred by the COVID-19 pandemic, Princeton researchers have developed a diagnostic tool to analyze chest X-rays for patterns in diseased lungs. The new tool could give doctors valuable information about a patient’s condition, quickly and cheaply, at the point of care. 

NJ ACTS Translating COVID-19 from Bench to Bedside
May 11, 2020

Read about the Rutgers Health Care Worker Corona Cohort Study, Princeton's efforts to design simplified ventilators and NJIT's pathogen resistant PPE. 

New Coronavirus Test Developed at Rutgers Can Screen Thousands and it’s as Simple as a Spit in a Tube
April 1, 2020

In what could represent a major advance in the fight against coronavirus, a Rutgers University research lab says it has developed a new test using existing automated technology able to analyze tens of thousands of patient samples each day to detect COVID-19.

Biostatistics, Epidemiology and Research Design Mini-Methods Grants - Apply By May 15
March 19, 2020

The NJ ACTS Biostatistics, Epidemiology and Research Design (BERD) Core is pleased to announce a call for applications for the Year 2 BERD Mini-Methods Grants Program.

BERD is soliciting proposals for one-year awards of up to $25,000 from investigators developing methodology in study design, measurement, statistical analysis, and…

NJ ACTS Pilot Grants Program Now Accepting Applications - Due May 1
Feb. 21, 2020

The NJ ACTS 2020 Pilot Grants Program is supported by a grant from the National Institutes of Health/National Center for Advancing Translational Sciences, as well as funds from the New Jersey Health Foundation.

There are 5 categories for potential pilot projects with awards up to $110,000 available.

Translational and Clinical…
NJ ACTS Announces the Partnership and Innovation Accelerator Pilot Grant Program (PIAP) Awardees
Dec. 18, 2019

NJ ACTS is excited to announce the awardees of the 2019 Partnership and Innovation Accelerator Pilot Grant Program (PIAP), Usha Ramachandran, MD and Helmut Zarbl, PhD. Continue to read full…

NJ ACTS Finds Universities Teaming Up to Transform NJ Health Care
Dec. 8, 2019

New Jersey residents will have access to the newest clinical trials and medical breakthroughs as a result of an innovative consortium between Rutgers University, Princeton University and the New Jersey Institute of Technology.

Organized by that consortium, the New Jersey Alliance for Clinical and Translational Science (NJACTS) –…

Princeton University Collaborates with Rutgers Cancer Institute as part of a Research Consortium to Address Cancer Burden
April 19, 2019
$15.1M Award from National Cancer Institute Recognizes Treatment, Prevention Efforts and Research Consortium with Princeton University
Princeton Receives $29 Million NIH Translational Science Grant with Rutgers and NJIT
March 11, 2019

A team led by the Rutgers Institute for Translational Medicine and Science that includes Princeton University and the New Jersey Institute of Technology has received a National Institutes of Health grant for $29 million over five years for joining the NIH's Clinical and Translational Science Awards Program (CTSA). The CTSA program at Rutgers…